Sichuan Goldstone Asia Pharmaceutical Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €132.50M -8.8% €11.03M -27.3% 8.3% -0.021 pp €27.77M +6.4% 21.0% +0.030 pp
    €145.34M -2.7% €15.17M -42.3% 10.4% -0.072 pp €26.11M -42.4% 18.0% -0.12 pp
    €149.36M +17.9% €26.30M +229.1% 17.6% +0.11 pp €45.34M +70.1% 30.4% +0.093 pp
    €126.63M +35.5% €7.99M -109.7% 6.3% +0.95 pp €26.66M +31.9% 21.0% -0.0057 pp
    €93.43M -22.7% -€82.66M -671.5% -88.5% -1.0 pp €20.20M -21.3% 21.6% +0.0037 pp
    €120.87M +3.6% €14.46M -19.3% 12.0% -0.034 pp €25.68M -5.4% 21.2% -0.020 pp
    €116.68M +37.9% €17.93M +28.7% 15.4% -0.011 pp €27.15M +9.9% 23.3% -0.059 pp
    €84.62M +333.5% €13.93M +353.9% 16.5% +0.0074 pp €24.70M +85.4% 29.2% -0.39 pp
    €19.52M +38.7% €3.07M +9.2% 15.7% -0.042 pp €13.33M +89.1% 68.3% +0.18 pp
    €14.08M -32.2% €2.81M -27.2% 20.0% +0.014 pp €7.05M +26.4% 50.1% +0.23 pp
    €20.77M -27.6% €3.86M -34.3% 18.6% -0.019 pp €5.57M +2.3% 26.8% +0.078 pp
    €28.68M -9.7% €5.88M -14.0% 20.5% -0.010 pp €5.45M +5.5% 19.0% +0.027 pp
    €31.75M +14.2% €6.83M +5.4% 21.5% -0.018 pp €5.16M -34.1% 16.3% -0.12 pp
    €27.81M €6.49M 23.3% €7.83M 28.2%

    Notifications